Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Melanoma 6Lung Neoplasms 6Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Breast Neoplasms 3Brain Neoplasms 3Stomach Neoplasms 2Sarcoma 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1

Interventions

Thiotepa 2Melphalan 2Cyclophosphamide 2fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Muromonab-CD3 1Immunotherapy 1Drug Therapy 1Busulfan 1Antilymphocyte Serum 1Antibodies 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Histiocytosis × Immunotherapy × Clear all
NCT00145626 2017-06-19

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Completed
40 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡